{"log_id": 8946560451014844194, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.00146, "average": 0.988335, "min": 0.762729}, "location": {"width": 972, "top": 155, "height": 50, "left": 90}, "words": "在实体瘤(即GIST)患者中,血液学毒性的发生率比Ph+白血病患者中的少,伴发的34级中"}, {"probability": {"variance": 3e-06, "average": 0.998887, "min": 0.993777}, "location": {"width": 505, "top": 214, "height": 40, "left": 92}, "words": "性粒细胞减少和血小板减少分别约为10%和1%"}, {"probability": {"variance": 1e-06, "average": 0.998897, "min": 0.997997}, "location": {"width": 49, "top": 274, "height": 26, "left": 95}, "words": "出血"}, {"probability": {"variance": 5e-05, "average": 0.998081, "min": 0.95582}, "location": {"width": 921, "top": 301, "height": 47, "left": 142}, "words": "在基线时骨髓功能受损的CML患者中,中枢神经系统和胃肠道出血并不罕见。在白血"}, {"probability": {"variance": 1e-06, "average": 0.999251, "min": 0.994625}, "location": {"width": 969, "top": 349, "height": 48, "left": 94}, "words": "病患者急性发病群体中,出血是公认的并发症之一,可能是由血小板减少,或不太常见的血"}, {"probability": {"variance": 0, "average": 0.999632, "min": 0.99825}, "location": {"width": 968, "top": 397, "height": 47, "left": 97}, "words": "小板功能异常造成的。然而,在使用伊马替尼治疗中并非所有患者出现的中枢神经系统和胃"}, {"probability": {"variance": 3e-06, "average": 0.99905, "min": 0.994319}, "location": {"width": 366, "top": 454, "height": 38, "left": 97}, "words": "肠道出血都是由于血小板减少引起"}, {"probability": {"variance": 0.00086, "average": 0.993975, "min": 0.818891}, "location": {"width": 922, "top": 493, "height": 46, "left": 146}, "words": "临床上显著的出血最常见的表现为胃肠道出血,最常发生于晚期CML患者和转移性"}, {"probability": {"variance": 0.002878, "average": 0.989556, "min": 0.654186}, "location": {"width": 946, "top": 541, "height": 48, "left": 97}, "words": "GIST患者中,出血可能是潜在疾病的一部分,来自于肿瘤出血/肿瘤坏死的肿瘤出血。在"}, {"probability": {"variance": 2.7e-05, "average": 0.997734, "min": 0.980642}, "location": {"width": 811, "top": 592, "height": 44, "left": 98}, "words": "线CML和GIST辅助治疗中,观察到的胃肠道出血的发生频率通常是最低的"}, {"probability": {"variance": 7.9e-05, "average": 0.994078, "min": 0.973278}, "location": {"width": 173, "top": 652, "height": 29, "left": 100}, "words": "水肿和水液潴留"}, {"probability": {"variance": 5e-06, "average": 0.999201, "min": 0.9888}, "location": {"width": 911, "top": 685, "height": 45, "left": 147}, "words": "水肿是在使用伊马替尼治疗各适应症的所有患者中,50%以上会出现的一种常见的毒性"}, {"probability": {"variance": 1e-06, "average": 0.999407, "min": 0.994838}, "location": {"width": 971, "top": 733, "height": 46, "left": 99}, "words": "水肿呈剂量相关性,其发生似乎与血浆水平有关系。最常见的表现是眶周水肿,下肢水肿在"}, {"probability": {"variance": 1e-05, "average": 0.998747, "min": 0.981915}, "location": {"width": 973, "top": 784, "height": 45, "left": 101}, "words": "某种程度上不太常见。通常不需要特殊治疗。其他水液潴留事件发生更为少见,但由于解剖"}, {"probability": {"variance": 1e-06, "average": 0.999278, "min": 0.993943}, "location": {"width": 945, "top": 829, "height": 46, "left": 104}, "words": "部位的位置不同,某些水液潴留可能存在潜在严重性。最常见的水液潴留事件是胸腔积液"}, {"probability": {"variance": 3.9e-05, "average": 0.997431, "min": 0.961931}, "location": {"width": 970, "top": 878, "height": 45, "left": 104}, "words": "最常见于晚期CML和转移性GIST患者中。在水肿和水液潴留的患者中,发生心力衰竭的频"}, {"probability": {"variance": 4e-06, "average": 0.998781, "min": 0.988152}, "location": {"width": 968, "top": 925, "height": 45, "left": 104}, "words": "率通常较低。晚期CML患者发生心力衰竭的几率比其他患者高,这可能是由于晚期CML患"}, {"probability": {"variance": 0.00127, "average": 0.99231, "min": 0.791313}, "location": {"width": 798, "top": 975, "height": 45, "left": 105}, "words": "者的医疗状况较差。在水肿和水液潴留的患者中观察到的肾衰竭的趋势相同"}, {"probability": {"variance": 0.000639, "average": 0.993217, "min": 0.847504}, "location": {"width": 919, "top": 1021, "height": 47, "left": 154}, "words": "在一项临床研究中,在新诊断的CML患者中用伊马替尼与用IFN-a中提示充血性心力"}, {"probability": {"variance": 0.001977, "average": 0.988078, "min": 0.718074}, "location": {"width": 970, "top": 1070, "height": 48, "left": 107}, "words": "衰竭事件的发生率分别为1.5%与1.1%。在发生进展的CML(加速期或急变期),年龄较高或"}, {"probability": {"variance": 0.000777, "average": 0.994739, "min": 0.816706}, "location": {"width": 969, "top": 1118, "height": 47, "left": 108}, "words": "基线血红蛋白低于8g/dL的患者中发生充血性心力衰竭事件的频率明显较高。在用于各适应"}, {"probability": {"variance": 0.000133, "average": 0.996451, "min": 0.927935}, "location": {"width": 969, "top": 1165, "height": 48, "left": 108}, "words": "症治疗中,在CML患者中观察到CHF事件的发生频率较在GIST患者中高,这可能表明这"}, {"probability": {"variance": 0.000334, "average": 0.99575, "min": 0.879003}, "location": {"width": 967, "top": 1214, "height": 46, "left": 111}, "words": "些疾病的CHF相关危险因素中存在差异。此外,在对942例无法切除或转移性GIST患者的"}, {"probability": {"variance": 4.6e-05, "average": 0.998019, "min": 0.959908}, "location": {"width": 967, "top": 1260, "height": 49, "left": 110}, "words": " EORTC研究中,一项针对心脏事件公布的最新特殊安全性分析得出的结论是:伊马替尼在"}, {"probability": {"variance": 0.000176, "average": 0.996184, "min": 0.927901}, "location": {"width": 971, "top": 1310, "height": 48, "left": 110}, "words": "GIST患者中不会诱发左心室衰竭,观察到的发生率约为0.2%,而在先前存在心脏病的群体"}, {"probability": {"variance": 1e-06, "average": 0.999323, "min": 0.996647}, "location": {"width": 138, "top": 1375, "height": 27, "left": 113}, "words": "中可高达2%"}, {"probability": {"variance": 0, "average": 0.99957, "min": 0.998066}, "location": {"width": 272, "top": 1417, "height": 36, "left": 112}, "words": "皮疹和严重皮肤不良反应"}, {"probability": {"variance": 1e-06, "average": 0.999305, "min": 0.996387}, "location": {"width": 919, "top": 1453, "height": 45, "left": 161}, "words": "据报告,尽管继续治疗,全身性红斑,斑丘疹,瘙痒性皮疹可消退。部分患者可出现瘙"}, {"probability": {"variance": 1e-06, "average": 0.999448, "min": 0.995989}, "location": {"width": 947, "top": 1500, "height": 49, "left": 112}, "words": "痒,但不伴发皮疹,且有时会伴有表皮剥脱。部分患者再次暴露本品可导致皮疹再次出现"}], "language": 3}